130 related articles for article (PubMed ID: 35227594)
1. [Prognostic factors of acute radiodermatitis in breast cancer after adjuvant radiotherapy treated with RT3D or IMRT].
Thomas A; Keller A; Menoux I; Brahimi Y; Vigneron C; Le Fèvre C; Chambrelant I; Pietta GA; Guihard S; Clavier JB; Antoni D; Noël G
Cancer Radiother; 2022 Sep; 26(5):684-691. PubMed ID: 35227594
[TBL] [Abstract][Full Text] [Related]
2. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors.
Borm KJ; Loos M; Oechsner M; Mayinger MC; Paepke D; Kiechle MB; Combs SE; Duma MN
Radiat Oncol; 2018 Nov; 13(1):218. PubMed ID: 30404664
[TBL] [Abstract][Full Text] [Related]
3. Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
Krug D; Köder C; Häfner MF; Arians N; Harrabi SB; Koerber SA; Forster T; Schlampp I; Sohn C; Heil J; Hof H; Hörner-Rieber J; Debus J
Radiat Oncol; 2020 Oct; 15(1):235. PubMed ID: 33050920
[TBL] [Abstract][Full Text] [Related]
4. Relationships among patient characteristics, irradiation treatment planning parameters, and treatment toxicity of acute radiation dermatitis after breast hybrid intensity modulation radiation therapy.
Lee TF; Sung KC; Chao PJ; Huang YJ; Lan JH; Wu HY; Chang L; Ting HM
PLoS One; 2018; 13(7):e0200192. PubMed ID: 30011291
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of acute skin toxicity of breast radiotherapy using thermography: Results of a prospective single-centre trial.
Maillot O; Leduc N; Atallah V; Escarmant P; Petit A; Belhomme S; Sargos P; Vinh-Hung V
Cancer Radiother; 2018 May; 22(3):205-210. PubMed ID: 29678596
[TBL] [Abstract][Full Text] [Related]
6. [Acute toxicity of breast cancer irradiation with modulated intensity by tomotherapy
Aoulad N; Massabeau C; de Lafontan B; Vieillevigne L; Hangard G; Ciprian C; Chaltiel L; Moyal É; Izar F
Cancer Radiother; 2017 May; 21(3):180-189. PubMed ID: 28499662
[TBL] [Abstract][Full Text] [Related]
7. Incidence of radiodermatitis and factors associated with its severity in women with breast cancer: a cohort study.
Cavalcante LG; Domingues RAR; Junior BO; Fernandes MAR; Pessoa EC; Abbade LPF
An Bras Dermatol; 2024; 99(1):57-65. PubMed ID: 37657957
[TBL] [Abstract][Full Text] [Related]
8. Incidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy.
Vieira LAC; Menêses AG; Bontempo PSM; Simino GPR; Ferreira EB; Guerra ENDS; Reis PEDD
Rev Esc Enferm USP; 2022; 56():e20220173. PubMed ID: 36469486
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
[TBL] [Abstract][Full Text] [Related]
10. Clinically Significant Dermatitis During Adjuvant Radiotherapy for Invasive Breast Cancer.
Rades D; Kristiansen C; Timke C; Duma MN; Yu NY; Bartscht T; Janssen S
Anticancer Res; 2024 Apr; 44(4):1525-1531. PubMed ID: 38537981
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
12. Association of Skin Microbiome Dynamics With Radiodermatitis in Patients With Breast Cancer.
Hülpüsch C; Neumann AU; Reiger M; Fischer JC; de Tomassi A; Hammel G; Gülzow C; Fleming M; Dapper H; Mayinger M; Vogel M; Ertl C; Combs SE; Traidl-Hoffmann C; Borm KJ
JAMA Oncol; 2024 Apr; 10(4):516-521. PubMed ID: 38300584
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy.
Yang JF; Lee MS; Lin CS; Chao HL; Chen CM; Lo CH; Fan CY; Tsao CC; Huang WY
Medicine (Baltimore); 2016 Mar; 95(11):e3113. PubMed ID: 26986158
[TBL] [Abstract][Full Text] [Related]
14. Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy.
Rudat V; Nour A; Ghaida SA; Alaradi A
Radiat Oncol; 2016 Jul; 11():100. PubMed ID: 27473272
[TBL] [Abstract][Full Text] [Related]
15. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis.
Pardo Masferrer J; Murcia Mejía M; Vidal Fernández M; Alvarado Astudillo A; Hernández Armenteros ML; Macías Hernández V; Soto Pérez R; Mirada Ferre A
Clin Transl Oncol; 2010 Jan; 12(1):43-8. PubMed ID: 20080470
[TBL] [Abstract][Full Text] [Related]
17. Can we treat with radiation breast cancer patients with covid-19 infection? Results from a prospective study.
Allali S; Servois V; Beddok A; Fourquet A; Kirova Y
Cancer Radiother; 2022 Jun; 26(4):577-584. PubMed ID: 35165016
[TBL] [Abstract][Full Text] [Related]
18. Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy.
De Langhe S; Mulliez T; Veldeman L; Remouchamps V; van Greveling A; Gilsoul M; De Schepper E; De Ruyck K; De Neve W; Thierens H
BMC Cancer; 2014 Sep; 14():711. PubMed ID: 25252713
[TBL] [Abstract][Full Text] [Related]
19. Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor.
Cleary JF; Anderson BM; Eickhoff JC; Khuntia D; Fahl WE
Radiat Oncol; 2017 Dec; 12(1):201. PubMed ID: 29273054
[TBL] [Abstract][Full Text] [Related]
20. Correlation between toxicity and dosimetric parameters for adjuvant intensity modulated radiation therapy of breast cancer: a prospective study.
Pasquier D; Bataille B; Le Tinier F; Bennadji R; Langin H; Escande A; Tresch E; Darloy F; Carlier D; Crop F; Lartigau E
Sci Rep; 2021 Feb; 11(1):3626. PubMed ID: 33574446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
